These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7075609)

  • 41. Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine.
    Goldberg LI; Hsieh YY; Resnekov L
    Prog Cardiovasc Dis; 1977; 19(4):327-40. PubMed ID: 12536
    [No Abstract]   [Full Text] [Related]  

  • 42. Hemodynamic comparison of dopamine and dobutamine in the postoperative volume-loaded, pressure-loaded, and normal ventricle.
    DiSesa VJ; Brown E; Mudge GH; Collins JJ; Cohn LH
    J Thorac Cardiovasc Surg; 1982 Feb; 83(2):256-63. PubMed ID: 6977075
    [No Abstract]   [Full Text] [Related]  

  • 43. [A comparison of cardiovascular effects of dobutamine and dopamine (author's transl)].
    Hess W; Brückner JB; Schmidt D; Schweichel E; Tarnow J
    Z Kardiol; 1977 Oct; 66(10):537-44. PubMed ID: 919662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of dobutamine on left ventricular performance and myocardial metabolic demands in patients with ischemic heart disease.
    Côté P; Bourassa MG; Tubau JF; Enjalbert M; Vandormael M
    Clin Cardiol; 1984 Jan; 7(1):14-22. PubMed ID: 6705283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine.
    Fowler MB; Alderman EL; Oesterle SN; Derby G; Daughters GT; Stinson EB; Ingels NB; Mitchell RS; Miller DC
    Circulation; 1984 Sep; 70(3 Pt 2):I103-11. PubMed ID: 6744557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparison of the hemodynamic effects induced with dobutamine, isoproterenol and dopamine in patients with coronary insufficiency].
    Magnani B; Ambrosioni E; Maresta A
    Boll Soc Ital Cardiol; 1977; 22(9):1570-4. PubMed ID: 753335
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of ouabain on myocardial oxygen supply and demand in patients with chronic coronary artery disease. A hemodynamic, volumetric, and metabolic study in patients without heart failure.
    DeMots H; Rahimtoola SH; Kremkau EL; Bennett W; Mahler D
    J Clin Invest; 1976 Aug; 58(2):312-9. PubMed ID: 783197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine may preserve the myocardial oxygen balance better than dobutamine when administered with milrinone.
    Takamatsu I; Karasawa F; Okuda T
    Can J Anaesth; 2002 Nov; 49(9):968-72. PubMed ID: 12419727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Systemic and coronary haemodynamic effects of dobutamine and norepinephrine during metabolic acidosis].
    Schulte-Sasse U; Hess W; Schweichel E; Tarnow J; Brückner JB
    Anaesthesist; 1981 Sep; 30(9):455-60. PubMed ID: 7283111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent advances in digitalis research.
    Mason DT; Awan NA
    Am J Cardiol; 1979 May; 43(5):1056-9. PubMed ID: 433767
    [No Abstract]   [Full Text] [Related]  

  • 52. Hemodynamic aspects of the treatment of ischemic heart disease.
    Wellens D
    Angiology; 1977 Dec; 28(12):839-43. PubMed ID: 23714
    [No Abstract]   [Full Text] [Related]  

  • 53. [The haemodynamic effects of dobutamine and dopamine in patients with coronary artery disease. A study performed under general anaesthesia (author's transl)].
    Hess W; Brückner JB; von Faber du Faur J; Schmidt D; Tarnow J
    Anaesthesist; 1979 Jul; 28(7):316-21. PubMed ID: 314760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced cardiac efficiency with dobutamine after global ischemia.
    Ward HB; Einzig S; Wang T; Bianco R; Foker JE
    J Surg Res; 1982 Jul; 33(1):32-8. PubMed ID: 7087447
    [No Abstract]   [Full Text] [Related]  

  • 55. A guide to the rational use of dopamine, dobutamine and isoprenaline in patients who need inotropic support.
    Lipman J; Plit M
    S Afr Med J; 1984 Mar; 65(13):506-9. PubMed ID: 6369567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inotropic agents and functional recovery from ischemic cardiac arrest.
    Hearse DJ; Stewart DA; Braimbridge MV
    Thorac Cardiovasc Surg; 1979 Jun; 27(3):153-9. PubMed ID: 462463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haemodynamic effects of a new inotropic agent (dobutamine) in chronic cardiac failure.
    Beregovich J; Bianchi C; D'Angelo R; Diaz R; Rubler S
    Br Heart J; 1975 Jun; 37(6):629-34. PubMed ID: 1148061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the effects of amrinone and sodium nitroprusside on haemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy.
    Wilmshurst PT; Thompson DS; Juul SM; Jenkins BS; Coltart DJ; Webb-Peploe MM
    Br Heart J; 1984 Jul; 52(1):38-48. PubMed ID: 6743422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The pharmacology of dobutamine.
    Ruffolo RR
    Am J Med Sci; 1987 Oct; 294(4):244-8. PubMed ID: 3310640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.